Stocks analysis

Analysis for WELL

  • 📈 Growth — 28/30
  • 💰 Profitability — 16/20
  • 🏦 Financial Health — 18/20
  • 💵 Valuation — 12/20
  • ⚠️ Risk — 6/10
Overall Score: 80/100

Summary:


📈 Growth & Financial Trajectory

Over 8 quarters, WELLTOWER's revenue rose from about $1.86B in 2024-Q1 to about $3.35B in 2026-Q1, roughly an 80% increase. Net income grew from about $131.6M to about $752.3M (continuing operations after tax), signaling durable earnings expansion despite quarterly fluctuations. Gross profit advanced from $762.8M to $1.30B, with margins generally in the high 30s to low 40s, supporting rising operating income.

💰 Margins & Cash Flow

Gross margin hovered around 39–41%. Operating income remained positive across quarters as costs were well managed. Net cash flow from operating activities stayed positive in most quarters, e.g., $670.0M in 2026-Q1. Investing activity was a recurring cash outflow, leading to negative quarterly total cash flow in several periods; financing flows varied and helped liquidity.

🛡️ Balance Sheet & Liquidity

Balance sheet strength is evident: current assets near $60–67B against current liabilities around $17–24B, implying a robust current ratio. Equity attributable to parent is typically in the mid‑to‑high teens to mid‑$40B range, and long‑term debt around $18–$20B. In Q1 2026, total assets were about $67.2B, current liabilities about $22.3B, and equity about $44.7B, with debt support from a strong asset base. This structure supports liquidity and resilience across cycles.

⚠️ Key Drivers & Risks

  • Drivers: Aging population drives demand for healthcare real estate; long‑term leases and stable occupancy underpin recurring rental income.
  • Risks: Interest‑rate sensitivity and real estate cycles; occupancy/renewal volatility and valuation sensitivity to rate moves.